Breast cancer metastasis: markers and models
The DOI matches its Crossref record; 115 of the 115 references it cites were found in a registry or an index.
Abstract
Breast cancer starts as a local disease, but it can metastasize to the lymph nodes and distant organs. At primary diagnosis, prognostic markers are used to assess whether the transition to systemic disease is likely to have occurred. The prevailing model of metastasis reflects this view--it suggests that metastatic capacity is a late, acquired event in tumorigenesis. Others have proposed the idea that breast cancer is intrinsically a systemic disease. New molecular technologies, such as DNA microarrays, support the idea that metastatic capacity might be an inherent feature of breast tumours. These data have important implications for prognosis prediction and our understanding of metastasis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Immune cells were shown to both enhance and inhibit malignant cells proliferation, migration, and metastasis [125-128].”
From Microfluidic modelling of the tumor microenvironment for anti-cancer drug development (2019) · cites this paper as [125]
In the citing paper
“Chemical gradients play an important role in tumor cell invasion of metastatic cancer [195,196] as it significantly directs the migration and differentiation of tumor cells.”
From Microfluidic modelling of the tumor microenvironment for anti-cancer drug development (2019) · cites this paper as [196]
In the citing paper
“Metastasis is the leading cause of death from breast cancer1, 37-39.”
From Liposomal Formulation of HIF-1α Inhibitor Echinomycin Eliminates Established Metastases of Triple-negative Breast Cancer (2020) · cites this paper as [1]
Citations
Cites
Molecular portraits of human breast tumours
Perou, C. M., Sørlie, T., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., Rees, C. A., Pollack, J. R., Ross, D. T., Johnsen, H., Akslen, L. A., et al. (2000) · Nature · doi:10.1038/35021093 · Cited by 16,261
Cluster analysis and display of genome-wide expression patterns
Eisen, M. B., Spellman, P. T., Brown, P. O., & Botstein, D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.25.14863 · Cited by 16,184
Slamon, D. J., Clark, G. M., Wong, S. G., Levin, W. J., Ullrich, A., & McGuire, W. L. (1987) · Science · doi:10.1126/science.3798106 · Cited by 11,760 · cited 1×
“ERBB2 is overexpressed due to gene amplification in 15–30% of human breast cancer”
Golub, T. R., Slonim, D. K., Tamayo, P., Huard, C., Gaasenbeek, M., Mesirov, J. P., Coller, H., Loh, M. L., Downing, J. R., Caligiuri, M. A., et al. (1999) · Science · doi:10.1126/science.286.5439.531 · Cited by 11,516
Slamon, D. J., Leyland-Jones, B., Shak, S., Fuchs, H., Paton, V., Bajamonde, A., Fleming, T., Eiermann, W., Wolter, J., Pegram, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103153441101 · Cited by 11,500
Sørlie, T., Perou, C. M., Tibshirani, R., Aas, T., Geisler, S., Johnsen, H., Hastie, T., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.191367098 · Cited by 10,938
Prospective identification of tumorigenic breast cancer cells
Al-Hajj, M., Wicha, M. S., Benito-Hernandez, A., Morrison, S. J., & Clarke, M. F. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0530291100 · Cited by 10,370
Stem cells, cancer, and cancer stem cells
Reya, T., Morrison, S. J., Clarke, M. F., & Weissman, I. L. (2001) · Nature · doi:10.1038/35102167 · Cited by 9,738
Gene expression profiling predicts clinical outcome of breast cancer
van 't Veer, L. J., Dai, H., van de Vijver, M. J., He, Y. D., Hart, A. A. M., Mao, M., Peterse, H. L., van der Kooy, K., Marton, M. J., Witteveen, A. T., et al. (2002) · Nature · doi:10.1038/415530a · Cited by 9,536
Research works printed but not linked: 2
- Fidler, I. J. Metastasis: quantitative analysis of distribution and fate of tumour embolilabeled with 125 I-5-iodo-2′-deoxyuridine. J. Natl Cancer Inst. 45, 773–782 (1970).
- Leighton, J. Inherent malignancy of cancer cells possibly limited by genetically differing cells in the same tumour. Acta Cytol. 9, 138–140 (1965).
Cited by
Items 601–700 of 1,003
VEGF-C-VEGFR3/Flt4 axis regulates mammary tumor growth and metastasis in an autocrine manner.
Varney, M. L., & Singh, R. K. (2015) · Europe PMC (PubMed Central) · Cited by 50
Wang, Y., Tai, Q., Zhang, J., Kang, J., Gao, F., Zhong, F., Cai, L., Fang, F., & Gao, Y. (2018) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmy119 · Cited by 50
Radiation-induced lung damage promotes breast cancer lung-metastasis through CXCR4 signaling
Feys, L., Descamps, B., Vanhove, C., Vral, A., Veldeman, L., Vermeulen, S. J. T., Wagter, C. D., Bracke, M., & Wever, O. D. (2015) · Oncotarget · doi:10.18632/oncotarget.5666 · Cited by 52
“The difference in our in vivo model is that we first irradiated the lung and waited for metastasis to grow [22].”
BackgroundSignaling pathways in breast cancer metastasis - novel insights from functional genomics
Blanco, M. A., & Kang, Y. (2011) · Breast Cancer Research · doi:10.1186/bcr2831 · Cited by 50
“Th e early waves of clinical microarray studies found that gene expression profi les in primary tumors could discriminate breast cancer patients with good prognosis from those with poor prognosis [6].”
BackgroundUddin, N., Kim, R., Yoo, K.-C., Kim, Y., Cui, Y., Kim, I., Suh, Y., & Lee, S. (2015) · Cancer Science · doi:10.1111/cas.12668 · Cited by 53
Sun, S., Han, Y., Liu, J., Fang, Y., Tian, Y., Zhou, J., Ma, D., & Wu, P. (2014) · PLoS ONE · doi:10.1371/journal.pone.0091610 · Cited by 54
Tissue factor-specific ultra-bright SERRS nanostars for Raman detection of pulmonary micrometastases
Nayak, T. R., Andreou, C., Oseledchyk, A., Marcus, W. D., Wong, H. C., Massagué, J., & Kircher, M. F. (2017) · Nanoscale · doi:10.1039/c6nr08217c · Cited by 49
A review of S100 protein family in lung cancer
Wang, T., Huo, X., Chong, Z., Khan, H., Liu, R. R., & Wang, T. (2017) · Clinica Chimica Acta · doi:10.1016/j.cca.2017.11.010 · Cited by 50
Wang, Z., Ma, Y., Yu, X., Niu, Q., Han, Z., Wang, H., Li, T., Fu, D., Achilefu, S., Qian, Z., et al. (2018) · Advanced Functional Materials · doi:10.1002/adfm.201800732 · Cited by 52
Triple Negative Breast Cancer Profile, from Gene to microRNA, in Relation to Ethnicity
Gupta, I., Sareyeldin, R. M., Al‐Hashimi, I., Al-Thawadi, H., Farsi, H. F. A., Vranić, S., & Moustafa, A. A. (2019) · Cancers · doi:10.3390/cancers11030363 · Cited by 58
“Generally, breast cancer cells metastasize to the bone, liver, lung and brain [16].”
BackgroundKúdela, E., Samec, M., Koklesová, L., Líšková, A., Kubatka, P., Kozubík, E., Rokos, T., Pribulová, T., Gabonova, E., Smolár, M., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21207691 · Cited by 52
Liu, Y., Lin, Z., Zheng, Z., Zhang, Y., & Shui, L. (2022) · ACS Sensors · doi:10.1021/acssensors.1c02692 · Cited by 49
Role of TWEAK and Fn14 in tumor biology
Jeffrey, A. W. (2006) · Frontiers in bioscience · doi:10.2741/2270 · Cited by 51
Free Base Lysine Increases Survival and Reduces Metastasis in Prostate Cancer Model
Ibrahim‐Hashim, A., Wojtkowiak, J. W., & Ribeiro, M. D. L. C. (2011) · Journal of Cancer Science & Therapy · doi:10.4172/1948-5956.s1-004 · Cited by 53
GRAMD1B regulates cell migration in breast cancer cells through JAK/STAT and Akt signaling
Khanna, P., Lee, J. S., Sereemaspun, A., Lee, H., & Baeg, G. H. (2018) · Scientific Reports · doi:10.1038/s41598-018-27864-6 · Cited by 48
Harmine inhibits breast cancer cell migration and invasion by inducing the degradation of Twist1
Nafie, E. H. O., Lolarga, J., Lam, B., Guo, J., Abdollahzadeh, E., Rodriguez, S., Glackin, C. A., & Liu, J. (2021) · PLoS ONE · doi:10.1371/journal.pone.0247652 · Cited by 48
Klopfleisch, R., Klose, P., & Gruber, A. D. (2010) · Veterinary Pathology · doi:10.1177/0300985810363904 · Cited by 60
Nanni, P., Gatta, V., Menotti, L., Giovanni, C. D., Ianzano, M. L., Palladini, A., Grosso, V., Dall’Ora, M., Croci, S., Nicoletti, G., et al. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003155 · Cited by 55
Ma, J., LU, H., Wang, S., CHEN, B., Liu, Z., KE, X., Liu, T., & Fu, J. (2015) · International Journal of Oncology · doi:10.3892/ijo.2015.2888 · Cited by 48
Zhao, J., Ni, H., Ma, Y., Li, D., Dai, J., Zhao, F., Yan, X., Lü, B., Xu, H., & Guo, Y. (2006) · Human Pathology · doi:10.1016/j.humpath.2006.08.005 · Cited by 50
Abu, N., Akhtar, M. N., Yeap, S. K., Lim, K. L., Ho, W. Y., Abdullah, M. P., Ho, C. L., Omar, A. R., Ismail, J., & Alitheen, N. B. (2016) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-016-1046-8 · Cited by 52
Microdroplet chain array for cell migration assays
Ma, Y., Pan, J.-Z., Zhao, S.-P., Lou, Q., Zhu, Y., & Fang, Q. (2016) · Lab on a Chip · doi:10.1039/c6lc00823b · Cited by 50
Amith, S. R., & Fliegel, L. (2017) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.01.004 · Cited by 51
Bugan, I., Kucuk, S., Karagöz, Z., Fraser, S. P., Kaya, H., Dodson, A. R., Foster, C. S., Altun, S., & Djamgoz, M. B. A. (2019) · Prostate Cancer and Prostatic Diseases · doi:10.1038/s41391-019-0128-3 · Cited by 48
An order-to-disorder structural switch activates the FoxM1 transcription factor
Marceau, A. H., Brison, C. M., Nerli, S., Arsenault, H. E., McShan, A. C., Chen, E., Lee, H., Benanti, J. A., Sgourakis, N. G., & Rubin, S. M. (2019) · eLife · doi:10.7554/elife.46131 · Cited by 55
Direcks, W. G. E., Berndsen, S. C., Proost, N., Peters, G. J., Balzarini, J. M., Spreeuwenberg, M. D., Lammertsma, A. A., & Molthoff, C. F. M. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604523 · Cited by 48
Masoudi-Khoram, N., Bigdeli, B., Nikoofar, A., & Goliaei, B. (2016) · Journal of Breast Cancer · doi:10.4048/jbc.2016.19.1.18 · Cited by 48
Liu, Z., Ni, S., Yang, C., Sun, W., Huang, D., Su, H., Shu, J., & Qin, N. (2021) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2021.104715 · Cited by 50
Heterometallic nanomaterials: activity modulation, sensing, imaging and therapy
Li, S., Wang, A., Yuan, P.-X., Mei, L.-P., Zhang, L., & Feng, J. (2022) · Chemical Science · doi:10.1039/d2sc00460g · Cited by 47
miR-30e* is an independent subtype-specific prognostic marker in breast cancer
D’Aiuto, F., Callari, M., Dugo, M., Merlino, G., Musella, V., Miodini, P., Paolini, B., Cappelletti, V., & Daidone, M. G. (2015) · British Journal of Cancer · doi:10.1038/bjc.2015.206 · Cited by 50
“It is well known that the main cause of death for breast cancer is the development of metastasis at distant sites, rather than the primary tumor (Weigelt et al, 2005), which justifies our analyses in the second cohort.”
BackgroundMolitor, T. P., & Traktman, P. (2013) · Oncogenesis · doi:10.1038/oncsis.2013.11 · Cited by 47
Bai, J., Yong, H., Chen, F., Mei, P.-J., Liu, H., Li, C., Pan, Z., Wu, Y., & Zheng, J. (2013) · Annals of Oncology · doi:10.1093/annonc/mdt147 · Cited by 47
Inhibiting metastasis of breast cancer cells in vitro using gold nanorod-siRNA delivery system
Zhang, W., Meng, J., Ji, Y., Li, X., Kong, H., Wu, X., & Xu, H. (2011) · Nanoscale · doi:10.1039/c1nr10573f · Cited by 47
EW-7195, a novel inhibitor of ALK5 kinase inhibits EMT and breast cancer metastasis to lung
Park, C., Son, J., Jin, C. H., Nam, J., Kim, D., & Sheen, Y. Y. (2011) · European Journal of Cancer · doi:10.1016/j.ejca.2011.07.007 · Cited by 48
“novel small molecule inhibitor of ALK5, 3-((4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-5-(6-methyl-”
MethodInfluentialUsing second harmonic generation to predict patient outcome in solid tumors
Burke, K. A., Smid, M., Dawes, R. P., Timmermans, M. A. M., Salzman, P., van Deurzen, C. H. M., Beer, D. G., Foekens, J. A., & Brown, E. B. (2015) · BMC Cancer · doi:10.1186/s12885-015-1911-8 · Cited by 47
Evodiamine selectively targets cancer stem-like cells through the p53-p21-Rb pathway
Han, S., Woo, J. K., Jung, Y., Jeong, D., Kang, M., Yoo, Y., Lee, H., Oh, S. H., Ryu, J., & Kim, W. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.12.066 · Cited by 47
Kim, J. Y., Lee, N., Kim, Y. J., Cho, Y., An, H., Oh, E., Cho, T.-M., Sung, D., & Seo, J. H. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.11.022 · Cited by 47
Gueder, N., Allan, G., Telliez, M., Hague, F., Fernández, J. M. G., Sánchez‐Fernández, E. M., Mellet, C. O., Ahidouch, A., & Ouadid‐Ahidouch, H. (2017) · Journal of Cellular Physiology · doi:10.1002/jcp.25832 · Cited by 47
Alford, V. M., Kamath, A., Ren, X., Kumar, K., Gan, Q., Awwa, M., Tong, M., Seeliger, M. A., Cao, J. P., Ojima, I., et al. (2017) · ACS Chemical Biology · doi:10.1021/acschembio.7b00758 · Cited by 48
Proapoptotic PUMA targets stem-like breast cancer cells to suppress metastasis
Sun, Q., Lesperance, J., Wettersten, H. I., Luterstein, E., DeRose, Y. S., Welm, A. L., Cheresh, D. A., & Desgrosellier, J. S. (2017) · Journal of Clinical Investigation · doi:10.1172/jci93707 · Cited by 48
Macrophage inflammatory factors promote epithelial-mesenchymal transition in breast cancer
Bednarczyk, R. B., Tuli, N. Y., Hanly, E. K., Rahoma, G. M. B., Maniyar, R. R., Mittelman, A., Geliebter, J., & Tiwari, R. K. (2018) · Oncotarget · doi:10.18632/oncotarget.24917 · Cited by 50
“These high death rates can be primarily attributed to invasive breast cancers that metastasize and form secondary tumors [3].”
BackgroundXu, J., Sun, J., Ho, P. Y., Luo, Z., Ma, W., Zhao, W., Rathod, S., Fernandez, C. A., Venkataramanan, R., Xie, W., et al. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.04.025 · Cited by 49
Axl-mediated activation of TBK1 drives epithelial plasticity in pancreatic cancer
Cruz, V. H., Arner, E. N., Du, W., Bremauntz, A. E., & Brekken, R. A. (2019) · JCI Insight · doi:10.1172/jci.insight.126117 · Cited by 51
Liu, H., Ren, F. Z., Zhou, X., Ma, C., Wang, T., Zhang, H., Sun, Q., & Li, Z. (2019) · Analytical Chemistry · doi:10.1021/acs.analchem.9b03739 · Cited by 48
Lu, Z., Long, Y., Li, J., Li, J., Ren, K., Zhao, W., Wang, X., Xia, C., Wang, Y., Li, M., et al. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.08.047 · Cited by 51
Germ Line Polymorphism in Metastatic Progression
Hunter, K. W., & Crawford, N. P. S. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3705 · Cited by 47
Xu, C., Yang, K., Xuan, Z., Li, J., Liu, Y., Zhao, Y., Zheng, Z., Bai, Y., Shi, Z., Shao, C., et al. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-05944-4 · Cited by 46
“Breast cancer remains the leading cause of cancer deaths globally despite the advances in screening, diagnosis, and treatment [4].”
3D bioprinted breast tumor-stroma models for pre-clinical drug testing
González‐Callejo, P., Vázquez‐Aristizabal, P., García‐Astrain, C., de Aberasturi, D. J., Henriksen‐Lacey, M., Izeta, A., & Liz‐Marzán, L. M. (2023) · Materials Today Bio · doi:10.1016/j.mtbio.2023.100826 · Cited by 57
“Since multiple studies have shown that SLUG and TWIST-1 factors play important roles in promoting the EMT process, tumor progression and metastasis in TNBC cells [57,58], we conclude that our model does reflect the aggressive nature of TNBC tumors.”
ResultJiang, X., Wang, J., Lin, L., Du, L., Ding, Y., Zheng, F., Xie, H., Wang, Y., Hu, M., Liu, B., et al. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-02042-5 · Cited by 51
Using breast cancer cell CXCR4 surface expression to predict liposome binding and cytotoxicity
Guo, P., You, J., Yang, J., Moses, M. A., & Auguste, D. T. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.07.043 · Cited by 46
“Breast cancer cells are characterized by their ability to invade the surrounding tissue; tumor aggressiveness is described as the primary reason for the poor prognosis for breast cancer patients [4].”
GRK3 is essential for metastatic cells and promotes prostate tumor progression
Li, W., Ai, N., Wang, S., Bhattacharya, N., Vrbanac, V. D., Collins, M. P., Signoretti, S., Hu, Y., Boyce, F. M., Gravdal, K., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1320638111 · Cited by 46
Duan, H., Qu, L., & Shou, C. (2014) · Cancer Cell International · doi:10.1186/s12935-014-0135-3 · Cited by 52
Sobottka, B., Pestalozzi, B. C., Fink, D. A., Moch, H., & Varga, Z. (2016) · OncoImmunology · doi:10.1080/2162402x.2016.1153208 · Cited by 47
Kim, G., Lee, J. S., Park, M. H., & Yoon, J. H. (2017) · PLoS ONE · doi:10.1371/journal.pone.0187635 · Cited by 46
Elango, R., Alsaleh, K. A., Vishnubalaji, R., Manikandan, M., Ali, A., El-Aziz, N. A., Altheyab, A., Al‐Rikabi, A. C., Alfayez, M. A., Aldahmash, A. M., et al. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00756 · Cited by 46
Vuoso, D. C., D’Angelo, S., Ferraro, R., Caserta, S., Guido, S., Cammarota, M., Porcelli, M., & Cacciapuoti, G. (2020) · Scientific Reports · doi:10.1038/s41598-020-73092-2 · Cited by 48
Gross, B., Wongrakpanich, A., Francis, M. B., Salem, A. K., & Norian, L. A. (2014) · The AAPS Journal · doi:10.1208/s12248-014-9662-z · Cited by 49
FERM family proteins and their importance in cellular movements and wound healing (Review)
Bosanquet, D. C., Ye, L., Harding, K. G., & Jiang, W. G. (2014) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2014.1775 · Cited by 55
“In cancer, excessive cellular motility predisposes to metastasis, which is the cause of 90% of human cancer deaths (1,2).”
Paul, A., Danley, M., Saha, B., Tawfik, O. W., & Paul, S. (2015) · Scientific Reports · doi:10.1038/srep12520 · Cited by 49
Mittempergher, L., Saghatchian, M., Wolf, D. M., Michiels, S., Canisius, S., Dessen, P., Delaloge, S., Lazar, V., Benz, S. C., Tursz, T., et al. (2013) · Molecular Oncology · doi:10.1016/j.molonc.2013.07.006 · Cited by 50
Liu, S., Huang, W., Jin, M., Fan, B., Xia, G., & Gao, Z. (2015) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2015.11.009 · Cited by 45
Yuan, B., Jiang, X., Chen, Y., Guo, Q., Wang, K., Meng, X., Huang, Z., & Wen, X. (2017) · Talanta · doi:10.1016/j.talanta.2017.03.094 · Cited by 45
Câmara, A. L. D. S., Nagel, G., Tschiche, H. R., Cardador, C. M., Muehlmann, L. A., de Oliveira, D. M., Alvim, P. Q., Azevedo, R. B., Calderón, M., & Longo, J. P. F. (2017) · Nanomedicine · doi:10.2217/nnm-2017-0091 · Cited by 50
Proteomic characterization of early lung response to breast cancer metastasis in mice
Kurpińska, A., Suraj, J., Bonar, E., Zakrzewska, A., Stojak, M., Sternak, M., Jasztal, A., & Walczak, M. (2019) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2019.02.001 · Cited by 46
Li, P., Gao, M., Hu, Z., Xu, T., Chen, J., Ma, Y., Li, S., & Gu, Y. (2020) · Chemical Engineering Journal · doi:10.1016/j.cej.2020.128217 · Cited by 46
Polychromatic Microarrays: Simultaneous Multicolor Array Hybridization of Eight Samples
Shepard, J. R. E. (2006) · Analytical Chemistry · doi:10.1021/ac060011w · Cited by 45
CD44 targets Na+/H+ exchanger 1 to mediate MDA-MB-231 cells’ metastasis via the regulation of ERK1/2
Chang, G., Wang, J., Zhang, H., Zhang, Y., Wang, C.-X., Xu, H. Z., Zhang, H., Lin, Y., Ma, L., Li, Q., et al. (2014) · British Journal of Cancer · doi:10.1038/bjc.2013.809 · Cited by 46
Zhang, J.-W., Rubio, V., Zheng, S. S., & Shi, Z.-Z. (2009) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b0910009 · Cited by 45
Clinical Significance of CXC Chemokine Receptor-4 and c-Met in Childhood Rhabdomyosarcoma
Diomedi‐Camassei, F., McDowell, H. P., Ioris, M. A. D., Uccini, S., Altavista, P., Raschellà, G., Vitali, R., Mannarino, O., Sio, L. D., Cozzi, D. A., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-4446 · Cited by 45
Bailey, C. M., Liu, Y., Peng, G., Zhang, H., He, M., Sun, D., Zheng, P., Liu, Y., & Wang, Y. (2020) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2020.102278 · Cited by 44
Shirai, T., Revenko, A. S., Tibbitts, J. F., Ngo, A. T. P., Mitrugno, A., Healy, L. D., Johnson, J. S., Tucker, E. I., Hinds, M. T., Coussens, L. M., et al. (2019) · Blood Advances · doi:10.1182/bloodadvances.2019000250 · Cited by 44
Link, N., Aubel, C., Kelm, J. M., Marty, R. R., Greber, D., Djonov, V., Bourhis, J., Weber, W., & Fussenegger, M. (2006) · Nucleic Acids Research · doi:10.1093/nar/gnj014 · Cited by 45
Franci, C., Zhou, J., Jiang, Z., Modrusan, Z. D., Good, Z., Jackson, E. L., & Kouros‐Mehr, H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0058183 · Cited by 48
SPARCL1 suppresses metastasis in prostate cancer
Xiang, Y., Qiu, Q., Jiang, M., Jin, R., Lehmann, B. D., Strand, D. W., Jovanović, B., DeGraff, D. J., Zheng, Y., Yousif, D. A., et al. (2013) · Molecular Oncology · doi:10.1016/j.molonc.2013.07.008 · Cited by 44
Broselid, S., Cheng, B., Sjöström, M., Lövgren, K., Santiago, H. L. P. K.-D., Belting, M., Jirström, K., Malmström, P., Olde, B., Bendahl, P., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-2376 · Cited by 50
miR-340 suppresses cell migration and invasion by targeting MYO10 in breast cancer
Chen, C., SUN, Z.-L., Lu, X., Wu, W., Guo, W., Lu, J., Han, C., HUANG, J.-Q., & Fang, Y. (2015) · Oncology Reports · doi:10.3892/or.2015.4411 · Cited by 47
Different types of tumor vessels in breast cancer: morphology and clinical value
Senchukova, M. A., Nikitenko, N. V., Tomchuk, O. N., Zaitsev, N. V., & Aa, S. (2015) · SpringerPlus · doi:10.1186/s40064-015-1293-z · Cited by 44
“Using the notion of “metastatic cascade” (Engers and Gabbert 2000; Weigelt et al. 2005) it is extremely difficult to explain how the large portions of the tumor tissue are placed into the lumen of vessels.”
BackgroundUltraconserved long non-coding RNA uc.63 in breast cancer
Marini, A., Lena, A. M., Panatta, E., Ivan, C., Han, L., Liang, H., Annicchiarico‐Petruzzelli, M., Daniele, N. D., Calin, G. A., Candi, E., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.10572 · Cited by 47
“Genetic and epigenetic changes, as well as aberrant interactions with tumor microenvironment, drive a multistep process characterized by progressive deregulation of proliferation, survival, differentiation and metabolism, finally giving rise to aggressive and metastatic breast tumor [26, 27].”
BackgroundThe role of gap junctions in inflammatory and neoplastic disorders (Review)
Wong, P. F., Laxton, V., Srivastava, S., Chan, Y. W. F., & Tse, G. (2017) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2017.2859 · Cited by 47
Lai, Y., Chen, J., Wang, X., Wu, Y., Peng, H., Lin, X., & Wang, W. (2017) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-017-0564-7 · Cited by 51
Organ‐on‐a‐Chip Systems for Women's Health Applications
Nawroth, J. C., Rogal, J., Weiß, M., Brucker, S. Y., & Loskill, P. (2017) · Advanced Healthcare Materials · doi:10.1002/adhm.201700550 · Cited by 47
Chemical genomics reveals inhibition of breast cancer lung metastasis by Ponatinib via c-Jun
Shao, W., Li, S., Li, L., Lin, K., Liu, X., Wang, H., Wang, H., & Wang, D. (2018) · Protein & Cell · doi:10.1007/s13238-018-0533-8 · Cited by 48
HUNK phosphorylates EGFR to regulate breast cancer metastasis
Scalise, C. B., Phelps-Polirer, K., Dingle, I. P., Williams, C. J., Rhett, J. M., Eblen, S. T., Armeson, K. E., Hill, E. G., & Yeh, E. S. (2019) · Oncogene · doi:10.1038/s41388-019-1046-5 · Cited by 45
Tamoxifen/raloxifene loaded liposomes for oral treatment of breast cancer
Ağardan, N. B. M., Değim, Z., Yılmaz, Ş., Altıntaş, L., & Topal, T. (2020) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2020.101612 · Cited by 49
Tan, Y. S., Ooi, K. K., Ang, K. P., Akim, A. M., Cheah, Y. K., Halim, S. N. A., Seng, H., & Tiekink, E. R. T. (2015) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2015.06.009 · Cited by 47
Development of anticancer drugs based on the hallmarks of tumor cells
Bailón-Moscoso, N., Romero-Benavides, J. C., & Ostrosky‐Wegman, P. (2014) · Tumor Biology · doi:10.1007/s13277-014-1649-y · Cited by 52
Inns, J., & James, V. H. (2015) · The Breast · doi:10.1016/j.breast.2015.04.001 · Cited by 43
Cano, C. E., Hamidi, T., Garcia, M. N., Grasso, D., Loncle, C., Garcia, S., Calvo, E., Lomberk, G., Dusetti, N., Bartholin, L., et al. (2014) · Gut · doi:10.1136/gutjnl-2013-305221 · Cited by 40
Induction of IL-25 secretion from tumour-associated fibroblasts suppresses mammary tumour metastasis
Yin, S.-Y., Jian, F.-Y., Chen, Y.-H., Chien, S.-C., Hsieh, M.-C., Hsiao, P.-W., Lee, W.-H., Kuo, Y.-H., & Yang, N.-S. (2016) · Nature Communications · doi:10.1038/ncomms11311 · Cited by 43
Gore, J., Imasuen, I., Conteh, A. M., Craven, K. E., Cheng, M., & Korc, M. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.05.037 · Cited by 47
Mirzaie, Z. H., Irani, S., Mirfakhraie, R., Atyabi, S. M., Dinarvand, M., Dinarvand, R., Varshochian, R., & Atyabi, F. (2016) · Chemical Biology & Drug Design · doi:10.1111/cbdd.12814 · Cited by 43
Role of Akt2 in regulation of metastasis suppressor 1 expression and colorectal cancer metastasis
Agarwal, E., Robb, C. M., Smith, L., Brattain, M. G., Wang, J., Black, J. D., & Chowdhury, S. (2017) · Oncogene · doi:10.1038/onc.2016.460 · Cited by 44
“Akt is activated via a multistep process: receptor tyrosine kinases stimulate phosphatidylinositol 3-kinase, which in turn converts phosphatidylinositol (3,4)bisphosphate (PIP2) to phosphatidylinositol (3,4,5)-trisphosphate (PIP3) by phosphorylation at the 3′-position of the inositol ring.”
Molecular mechanisms of breast cancer metastasis by gene expression profile analysis
Zheng, T., Wang, A., Hu, D., & Wang, Y. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.7157 · Cited by 54
“In a number of patients, breast cancer has been demonstrated to be aggressive and metastasized to a distant site a short time following the detection of primary tumor, whereas in other cases the hallmark of metastases may not be evident for a longer period (5).”
InfluentialStimuli-Responsive Nanodiamond-Based Biosensor for Enhanced Metastatic Tumor Site Detection
Wang, X., Gu, M., Toh, T. B., Abdullah, N. L. B., & Chow, E. K. (2017) · SLAS TECHNOLOGY · doi:10.1177/2472630317735497 · Cited by 43
CDK5 Inhibition Abrogates TNBC Stem‐Cell Property and Enhances Anti‐PD‐1 Therapy
Bei, Y., Cheng, N., Chen, T., Shu, Y., Yang, Y., Yang, N., Zhou, X., Liu, B., Wei, J., Liu, Q., et al. (2020) · Advanced Science · doi:10.1002/advs.202001417 · Cited by 48
Immune System Effects on Breast Cancer
Amens, J. N., Bahçecioğlu, G., & Zorlutuna, P. (2021) · Cellular and Molecular Bioengineering · doi:10.1007/s12195-021-00679-8 · Cited by 48
Premkumar, V. G., Yuvaraj, S., Vijayasarathy, K., Gangadaran, S. G. D., & Sachdanandam, P. (2007) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/j.1742-7843.2007.00065.x · Cited by 43
Association of interleukin-10 gene variation with breast cancer prognosis
Gerger, A., Renner, W., Langsenlehner, T., Hofmann, G., Knechtel, G., Szkandera, J., Samonigg, H., Krippl, P., & Langsenlehner, U. (2009) · Breast Cancer Research and Treatment · doi:10.1007/s10549-009-0417-y · Cited by 43
“Metastasis accounts for *90% of cancer-related death and its impact in developed nations will likely escalate, which primarily reflects an aging population [2, 3].”
BackgroundEndo, M., Yamamoto, Y., Nakano, M., Masuda, T., Odagiri, H., Horiguchi, H., Miyata, K., Kadomatsu, T., Motokawa, I., Okada, S., et al. (2014) · The International Journal of Biological Markers · doi:10.5301/jbm.5000080 · Cited by 44
Chen, H., Chao, C., Lin, L.-L., Lu, C., Liu, K., Lii, C., & Li, C. (2013) · Archives of Toxicology · doi:10.1007/s00204-012-1003-3 · Cited by 43
Metadata
- Authors
- Weigelt, B., Peterse, J. L., & van't Veer, L. J.
- Affiliations
- The Netherlands Cancer Institute (NL)
- ORCID
- Weigelt, Britta
- Venue
- Nature Reviews Cancer
- Published
- 2005-08-01
- Volume
- 5
- Issue
- 8
- Pages
- 591-602
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2004280628
- Semantic Scholar
- 3bd1490d7b6c8daa59bd35260c6c71e39d3d62fa
- Cited by
- 2,232
- References
- 112
- Citations by year
- 2026: 34 · 2025: 69 · 2024: 90 · 2023: 111 · 2022: 139 · 2021: 154 · 2020: 159 · 2019: 147 · 2018: 140 · 2017: 191 · 2016: 162 · 2015: 152 · 2014: 121 · 2013: 104 · 2012: 88
- FWCI
- 5.73
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Breast Cancer Treatment Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mechanisms of cancer metastasis
- Keywords
- breast cancer, metastasis, prognostic factors, metastatic potential, lymph node metastasis, distant metastasis, carcinogenesis, DNA microarrays, systemic disease, metastasis model
- MeSH terms
- Breast Neoplasms, Female, Humans, Neoplasm Metastasis, Biomarkers, Tumor, Models, Animal
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.